Literature DB >> 31332434

Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy.

Christopher Cao1,2, Brian E Louie3, Franca Melfi4, Giulia Veronesi5, Rene Razzak3, Gaetano Romano4, Pierluigi Novellis5, Neel K Ranganath6, Bernard J Park1.   

Abstract

OBJECTIVES: Percentage-predicted forced expiratory volume in 1 s (FEV1) and diffusing capacity for carbon monoxide (DLCO), and their predicted postoperative (ppo) values are established prognostic factors for postoperative pulmonary complications after thoracotomy. However, their predictive value for minimally invasive pulmonary resections remains controversial. This study assessed the incidence of pulmonary complications after robotic lobectomy for primary lung cancer and analysed the predictive significance of FEV1 and DLCO.
METHODS: This was a retrospective analysis of patients who underwent robotic lobectomy from 4 institutions. Descriptive and comparative analyses were performed for patients who experienced pulmonary complications versus patients who did not, in relation to FEV1 and DLCO values. To identify thresholds for increased complications, patients were categorized into groups of 10% incremental increases in FEV1 and DLCO, and their ppo values.
RESULTS: From November 2002 to April 2018, 1088 patients underwent robotic lobectomy. Overall, 169 postoperative pulmonary complications occurred in 141 patients. Male gender and Eastern Cooperative Oncology Group grade ≥1 were associated with increased pulmonary complications on univariable analysis. Patients who experienced pulmonary complications had increased mortality (2.1% vs 0.2%, P = 0.017) and longer hospitalizations (9 vs 4 days, P < 0.001). Pulmonary complications were associated when FEV1 ≤60% and DLCO ≤50%, and when ppo FEV1 or DLCO was ≤50%; ppo FEV1 ≤50% (P < 0.001) and ppo DLCO ≤50% (P = 0.031) remained statistically significant on multivariable analysis.
CONCLUSIONS: Both FEV1 and DLCO were shown to be significant predictors of pulmonary complications. Furthermore, thresholds of percentage-predicted and ppo FEV1 and DLCO values were identified, below which pulmonary complications occurred significantly more frequently, suggesting their predictive values are particularly useful in patients with poorer pulmonary function.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Diffusing capacity for carbon monoxide; Forced expiratory volume in 1 s; Lobectomy; Pulmonary complications; Robotics

Mesh:

Year:  2020        PMID: 31332434      PMCID: PMC7761531          DOI: 10.1093/ejcts/ezz205

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.

Authors:  Mark F Berry; Nestor R Villamizar-Ortiz; Betty C Tong; William R Burfeind; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

2.  Lung function predicts pulmonary complications regardless of the surgical approach.

Authors:  Ruoyu Zhang; Sang Mee Lee; Chris Wigfield; Wickii T Vigneswaran; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2015-03-25       Impact factor: 4.330

3.  Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.

Authors:  Bryan M Burt; Andrzej S Kosinski; Joseph B Shrager; Mark W Onaitis; Tracey Weigel
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-13       Impact factor: 5.209

4.  Nationwide Assessment of Robotic Lobectomy for Non-Small Cell Lung Cancer.

Authors:  Ravi Rajaram; Sanjay Mohanty; David J Bentrem; Emily S Pavey; David D Odell; Ankit Bharat; Karl Y Bilimoria; Malcolm M DeCamp
Journal:  Ann Thorac Surg       Date:  2017-01-18       Impact factor: 4.330

5.  Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors?

Authors:  P Agostini; H Cieslik; S Rathinam; E Bishay; M S Kalkat; P B Rajesh; R S Steyn; S Singh; B Naidu
Journal:  Thorax       Date:  2010-09       Impact factor: 9.139

6.  Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity.

Authors:  Mark K Ferguson; Henning A Gaissert; Joshua D Grab; Shubin Sheng
Journal:  J Thorac Cardiovasc Surg       Date:  2009-09-26       Impact factor: 5.209

7.  The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer.

Authors:  Alessandro Brunelli; Anne Charloux; Chris T Bolliger; Gaetano Rocco; Jean-Paul Sculier; Gonzalo Varela; Marc Licker; Mark K Ferguson; Corinne Faivre-Finn; Rudolf Maria Huber; Enrico M Clini; Thida Win; Dirk De Ruysscher; Lee Goldman
Journal:  Eur J Cardiothorac Surg       Date:  2009-05-27       Impact factor: 4.191

8.  Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.

Authors:  DuyKhanh P Ceppa; Andrzej S Kosinski; Mark F Berry; Betty C Tong; David H Harpole; John D Mitchell; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

9.  Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.

Authors:  D J Kearney; T H Lee; J J Reilly; M M DeCamp; D J Sugarbaker
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

10.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Alessandro Brunelli; Anthony W Kim; Kenneth I Berger; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more
  7 in total

1.  Robotic surgery can extend surgical indication in patients with lung cancer and impaired function.

Authors:  Giulia Veronesi; Pietro Bruschini; Pierluigi Novellis
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

2.  Predictive model of postoperative pneumonia after neoadjuvant immunochemotherapy for esophageal cancer.

Authors:  Wei Wang; Yongkui Yu; Haibo Sun; Zongfei Wang; Yan Zheng; Guanghui Liang; Peinan Chen; Jiwei Cheng; Xiaoxia Xu; Funa Yang; Qi Liu; Weiqun Xing
Journal:  J Gastrointest Oncol       Date:  2022-04

Review 3.  Overview of the outcomes of robotic segmentectomy and lobectomy.

Authors:  Giulia Veronesi; Pierluigi Novellis; Gianluca Perroni
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

4.  Outcomes and quality of life after Robot-assisted lobectomy/segmentectomy for lung cancer compared to video-assisted thoracoscopic surgery: both three-port procedures performed by a single surgeon.

Authors:  Liang Zheng; Peng Song; Yanru Jiang; Xiao Fan; Chen Yang; Lei Zhang; Qianyun Wang
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

5.  Atypical Ductal Hyperplasia: Risk Factors for Predicting Pathologic Upgrade on Excisional Biopsy.

Authors:  Ko Woon Park; Boo-Kyung Han; Sun Jung Rhee; Soo Youn Cho; Eun Young Ko; Eun Sook Ko; Ji Soo Choi
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-10-18

6.  Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study.

Authors:  Christopher Uhlig; Ary Serpa Neto; Meta van der Woude; Thomas Kiss; Jakob Wittenstein; Benjamin Shelley; Helen Scholes; Michael Hiesmayr; Marcos Francisco Vidal Melo; Daniele Sances; Nesil Coskunfirat; Paolo Pelosi; Marcus Schultz; Marcelo Gama de Abreu
Journal:  BMC Anesthesiol       Date:  2020-07-22       Impact factor: 2.217

7.  Preoperative assessment for minimally invasive lung surgery: Need an update?

Authors:  Fairuz Boujibar; Francis-Edouard Gravier; Jean Selim; Jean-Marc Baste
Journal:  Thorac Cancer       Date:  2020-11-19       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.